8D8-13664-21441
2 vaccinations
4 coded responses
22 check-ins
4 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 941 / CA
- Registered
- 2021-02-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-09
Dose 1 — Pfizer-BioNTech
-
2021-02-11
Registered in v-safe
- 2021-02-11
-
2021-02-12
Survey response — days 1–6 daily, dose 1MedDRA: Fatigue, Injection site pain — Feeling: Good · Fatigue or tirednessFree text: The 1st and 2nd days, I was unusually fatigued. Some soreness at injection site to the touch. Slight queasiness 1st 24 hrs. Felt slightly warm but no fever or chills. Most symptoms gone by end of 3rd day. Tiredness very mild today and soreness at injection point nearly gone.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-23
-
2021-03-02
Dose 2 — Pfizer-BioNTech
- 2021-03-02
-
2021-03-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-04
-
2021-03-05
Survey response — days 1–6 daily, dose 2MedDRA: Diarrhoea — Feeling: Good · DiarrheaFree text: Very mild diarrhea.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-07
- 2021-03-08
-
2021-03-09
Survey response — day 7, dose 2MedDRA: Insomnia, No adverse event, Somnolence — Feeling: Good · Fatigue or tirednessFree text: It lingers but is mild enough that it doesnt interfere. Just hard to sleep during regular hours and hard to get up.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-16
- 2021-03-23
- 2021-03-30
- 2021-04-06
- 2021-04-13
- 2021-06-01
-
2021-08-31
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: GoodFree text: Standard cold symptoms; tested negative for Covid.MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2022-03-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-09 | Pfizer-BioNTech | |
| 2 | 2021-03-02 | Pfizer-BioNTech |
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): The 1st and 2nd days, I was unusually fatigued. Some soreness at injection site to the touch. Slight queasiness 1st 24 hrs. Felt slightly warm but no fever or chills. Most symptoms gone by end of 3rd day. Tiredness very mild today and soreness at injection point nearly gone.
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Very mild diarrhea.
Release 5 — day 7, dose 2
Systemic reaction (other): It lingers but is mild enough that it doesnt interfere. Just hard to sleep during regular hours and hard to get up.
Release 9 — 6 months, dose 2
Symptoms: Standard cold symptoms; tested negative for Covid.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | ✓ | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | · | ✓ |
| SRO | Diarrhoea | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Insomnia | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Somnolence | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release